1
TITLE: Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (TNBC)
AUTHORS: Wongchenko, MJ; Oliveira, M; Saura, C; Nuciforo, P; Calvo, I; Andersen, J; Passos I P Coelho; Gil G Gil; Bermejo, B; Patt, DA; Ciruelos, E; Singel, SM; Maslyar, DJ; Xu, N; de la Pena, L; Baselga, J; Gendreau, S; Isakoff, SJ;
PUBLISHED: 2019, SOURCE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 79, ISSUE: 4
INDEXED IN: WOS